New XLH study aims to unlock secrets of phosphate and bone health
NCT ID NCT07607600
First seen May 26, 2026 · Last updated Jun 10, 2026 · Updated 3 times
Summary
This study watches 100 adults with X-linked hypophosphatemia (XLH) who are already taking the medicine burosumab. Researchers want to see how phosphate levels in the blood change over time and how they relate to bone health and overall well-being. The goal is to better understand the disease and its treatment, not to test a new drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for X-LINKED HYPOPHOSPHATEMIA (XLH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Azienda Ospedaliera di Padova - U.O.C. di Gastroenterologia
Padova, 35128, Italy
-
Bone Research and Education Centre
Oakville, Ontario, L6M 1M1, Canada
-
CHU de Bicetre
Le Kremlin, 94275, France
-
Charite Campus Virchow
Berlin, 13353, Germany
-
Endokrinologikum Goettingen
Göttingen, 37075, Germany
-
Fondazione Policlinico Universitario Campus Bio-Medico
Rome, 00128, Italy
-
Fukuoka University - Fukuoka University Hospital
Fukuoka, Fukuoka, 814-0180, Japan
-
Hopital Cochin - APHP
Paris, 75014, France
-
Indiana University Hospital
Indianapolis, Indiana, 46202-5271, United States
-
Iseikai International General Hospital
Osaka, 530-0052, Japan
-
Istituto Auxologico Italiano
Milan, 20145, Italy
-
Japan Community Healthcare Organization Osaka Hospital
Osaka, 553-0003, Japan
-
Leiden University Medical Center (Leids Universitair Medisch Centrum (LUMC))
Leiden, 2333 ZA, Netherlands
-
Monash University - Monash Medical Centre (MMC)
Clayton, Victoria, 3168, Australia
-
Northern Sydney Cancer Centre-Royal North Shore Hospital (RNSH)
St Leonards, New South Wales, 2065, Australia
-
Office of Francesco Di Costanzo, MD
Sesto Fiorentino, Florence, 50019, Italy
-
Okayama Saiseikai Outpatient Center Hospital
Okayama, Okayama-ken, 700-0013, Japan
-
The Ohio State University Wexner Medical Center (OSUWMC) - CarePoint East
Columbus, Ohio, 43203, United States
-
The University of Tokyo Hospital
Bunkyo-ku, Tokyo, 113-8655, Japan
-
Universitat Wurzburg Koenig-Ludwig-Haus
Wuezburg, 97074, Germany
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232-8148, United States
-
Westmead Hospital
Westmead, New South Wales, 2145, Australia
-
Yale University School of Medicine
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.